Ishita Drugs and Industries Limited (BOM:524400)
70.00
0.00 (0.00%)
At close: Jan 22, 2026
BOM:524400 Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
| 171.64 | 149.97 | 151.88 | 120.72 | 140.9 | 139.49 | Upgrade | |
Revenue Growth (YoY) | 22.53% | -1.25% | 25.80% | -14.32% | 1.01% | -5.96% | Upgrade |
Cost of Revenue | 142.48 | 126.13 | 129.37 | 100.12 | 118.14 | 119.29 | Upgrade |
Gross Profit | 29.16 | 23.85 | 22.5 | 20.6 | 22.76 | 20.2 | Upgrade |
Selling, General & Admin | 13.81 | 13.83 | 13.42 | 12.98 | 11.85 | 11.02 | Upgrade |
Other Operating Expenses | 4.14 | 0 | - | - | - | - | Upgrade |
Operating Expenses | 19.04 | 14.93 | 14.53 | 14.28 | 13.15 | 12.48 | Upgrade |
Operating Income | 10.12 | 8.92 | 7.97 | 6.32 | 9.61 | 7.72 | Upgrade |
Interest Expense | -0.5 | -0.35 | -0.62 | -0.37 | -0.04 | -0.19 | Upgrade |
Interest & Investment Income | 3.36 | 3.36 | 2.8 | 2.01 | 1.06 | 3.14 | Upgrade |
Other Non Operating Income (Expenses) | 0.12 | -0.38 | -0.28 | -0.17 | -0.2 | -0.13 | Upgrade |
Pretax Income | 13.09 | 11.55 | 9.87 | 7.79 | 10.43 | 10.54 | Upgrade |
Income Tax Expense | 3.38 | 2.87 | 2.39 | 2.02 | 2.38 | 2.24 | Upgrade |
Net Income | 9.71 | 8.68 | 7.49 | 5.77 | 8.05 | 8.3 | Upgrade |
Net Income to Common | 9.71 | 8.68 | 7.49 | 5.77 | 8.05 | 8.3 | Upgrade |
Net Income Growth | 30.69% | 15.98% | 29.63% | -28.27% | -2.97% | 51.64% | Upgrade |
Shares Outstanding (Basic) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade |
Shares Outstanding (Diluted) | 3 | 3 | 3 | 3 | 3 | 3 | Upgrade |
EPS (Basic) | 3.26 | 2.90 | 2.50 | 1.93 | 2.69 | 2.77 | Upgrade |
EPS (Diluted) | 3.25 | 2.90 | 2.50 | 1.93 | 2.69 | 2.77 | Upgrade |
EPS Growth | 31.14% | 16.00% | 29.53% | -28.25% | -2.89% | 51.40% | Upgrade |
Free Cash Flow | -2.95 | -38.21 | 20.94 | -30.32 | 30.58 | -6.8 | Upgrade |
Free Cash Flow Per Share | -0.99 | -12.78 | 7.00 | -10.14 | 10.23 | -2.27 | Upgrade |
Gross Margin | 16.99% | 15.90% | 14.82% | 17.07% | 16.16% | 14.48% | Upgrade |
Operating Margin | 5.90% | 5.95% | 5.25% | 5.24% | 6.82% | 5.53% | Upgrade |
Profit Margin | 5.66% | 5.79% | 4.93% | 4.78% | 5.71% | 5.95% | Upgrade |
Free Cash Flow Margin | -1.72% | -25.48% | 13.79% | -25.11% | 21.70% | -4.87% | Upgrade |
EBITDA | 11.21 | 10.01 | 9.08 | 7.62 | 10.91 | 9.18 | Upgrade |
EBITDA Margin | 6.53% | 6.68% | 5.98% | 6.31% | 7.74% | 6.58% | Upgrade |
D&A For EBITDA | 1.09 | 1.1 | 1.12 | 1.29 | 1.3 | 1.46 | Upgrade |
EBIT | 10.12 | 8.92 | 7.97 | 6.32 | 9.61 | 7.72 | Upgrade |
EBIT Margin | 5.90% | 5.95% | 5.25% | 5.24% | 6.82% | 5.53% | Upgrade |
Effective Tax Rate | 25.80% | 24.85% | 24.18% | 25.92% | 22.82% | 21.27% | Upgrade |
Revenue as Reported | 175.49 | 153.33 | 154.68 | 122.73 | 141.97 | 142.63 | Upgrade |
Advertising Expenses | - | 0.02 | 0.02 | 0.15 | 0.04 | 0.04 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.